{"url_path":"/fda/drug/recalls/D-0510-2026","section_key":"summary","section_title":"DRUG Recall: Apotex Corp. — Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-04-08","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0510-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Apotex Corp."},"word_count":87,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0510-2026\n\n**Recalling firm:** Apotex Corp.\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-04-08\n**Report date:** 2026-04-22\n\n## Product\nDesmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0\n\n## Reason\nDefective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.\n\n## Affected lots\nLot #: VM4231, Exp 06/30/2027\n\n## Distribution\nU.S.A. Nationwide"}